|
1
|
A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder.
|
Biol Psychiatry
|
2005
|
2.01
|
|
2
|
A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder.
|
Biol Psychiatry
|
2005
|
1.87
|
|
3
|
Cardiovascular effects of longer-term, high-dose OROS methylphenidate in adolescents with attention deficit hyperactivity disorder.
|
J Pediatr
|
2009
|
1.60
|
|
4
|
Neurologic soft signs in schizophrenic patients treated with conventional and atypical antipsychotics.
|
J Clin Psychopharmacol
|
2005
|
1.49
|
|
5
|
Treating a child with Asperger's disorder and comorbid bipolar disorder.
|
Am J Psychiatry
|
2002
|
1.44
|
|
6
|
Antidepressant therapy can improve adherence to antiretroviral regimens among HIV-infected and depressed patients.
|
J Clin Psychopharmacol
|
2007
|
1.09
|
|
7
|
A prospective open-label trial of lamotrigine monotherapy in children and adolescents with bipolar disorder.
|
CNS Neurosci Ther
|
2010
|
0.98
|
|
8
|
An open-label trial of OROS methylphenidate in adults with late-onset ADHD.
|
CNS Spectr
|
2006
|
0.95
|
|
9
|
A randomized, 3-phase, 34-week, double-blind, long-term efficacy study of osmotic-release oral system-methylphenidate in adults with attention-deficit/hyperactivity disorder.
|
J Clin Psychopharmacol
|
2010
|
0.95
|
|
10
|
An open-label trial of aripiprazole monotherapy in children and adolescents with bipolar disorder.
|
CNS Spectr
|
2007
|
0.93
|
|
11
|
Novel therapeutic targets for autism.
|
Trends Pharmacol Sci
|
2008
|
0.92
|
|
12
|
A prospective open-label trial of extended-release carbamazepine monotherapy in children with bipolar disorder.
|
J Child Adolesc Psychopharmacol
|
2010
|
0.92
|
|
13
|
Reexamining Tic persistence and Tic-associated impairment in Tourette's Disorder: findings from a naturalistic follow-up study.
|
J Nerv Ment Dis
|
2004
|
0.92
|
|
14
|
Comparative acute efficacy and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder.
|
BMC Psychiatry
|
2007
|
0.90
|
|
15
|
An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder.
|
Biol Psychiatry
|
2003
|
0.88
|
|
16
|
Adjusting to life after esophagectomy: the experience of survivors and carers.
|
Qual Health Res
|
2009
|
0.88
|
|
17
|
A quick and reliable screening measure for OCD in youth: reliability and validity of the obsessive compulsive scale of the Child Behavior Checklist.
|
Compr Psychiatry
|
2006
|
0.87
|
|
18
|
Response to second generation antipsychotics in youth with comorbid bipolar disorder and autism spectrum disorder.
|
CNS Neurosci Ther
|
2010
|
0.87
|
|
19
|
Risperidone treatment for ADHD in children and adolescents with bipolar disorder.
|
Neuropsychiatr Dis Treat
|
2008
|
0.86
|
|
20
|
Partial ventilatory support modalities in acute lung injury and acute respiratory distress syndrome-a systematic review.
|
PLoS One
|
2012
|
0.85
|
|
21
|
Child behavior checklist clinical scales discriminate referred youth with autism spectrum disorder: a preliminary study.
|
J Dev Behav Pediatr
|
2010
|
0.83
|
|
22
|
Supply chain optimization for pediatric perioperative departments.
|
AORN J
|
2011
|
0.83
|
|
23
|
Do stimulants reduce the risk for cigarette smoking in youth with attention-deficit hyperactivity disorder? A prospective, long-term, open-label study of extended-release methylphenidate.
|
J Pediatr
|
2012
|
0.81
|
|
24
|
Autism, gut-blood-brain barrier, and mast cells.
|
J Clin Psychopharmacol
|
2008
|
0.81
|
|
25
|
A randomized, single-blind, substitution study of OROS methylphenidate (Concerta) in ADHD adults receiving immediate release methylphenidate.
|
J Atten Disord
|
2010
|
0.81
|
|
26
|
Atomoxetine in the treatment of adults with subthreshold and/or late onset attention-deficit hyperactivity disorder-not otherwise specified (ADHD-NOS): a prospective open-label 6-week study.
|
CNS Neurosci Ther
|
2010
|
0.80
|
|
27
|
Discriminant and concurrent validity of a simplified DSM-based structured diagnostic instrument for the assessment of autism spectrum disorders in youth and young adults.
|
BMC Psychiatry
|
2011
|
0.80
|
|
28
|
A prospective open-label trial of quetiapine monotherapy in preschool and school age children with bipolar spectrum disorder.
|
J Affect Disord
|
2011
|
0.80
|
|
29
|
A pilot open label prospective study of memantine monotherapy in adults with ADHD.
|
World J Biol Psychiatry
|
2012
|
0.79
|
|
30
|
Atomoxetine in children with attention-deficit hyperactivity disorder with prior stimulant therapy: a prospective open-label study.
|
Eur Child Adolesc Psychiatry
|
2009
|
0.78
|
|
31
|
An Open Trial of Sustained Release Bupropion for Attention-Deficit/Hyperactivity Disorder in Adults with ADHD plus Substance Use Disorders.
|
J ADHD Relat Disord
|
2010
|
0.77
|
|
32
|
The G51S purine nucleoside phosphorylase polymorphism is associated with cognitive decline in Alzheimer's disease patients.
|
Hum Psychopharmacol
|
2007
|
0.75
|
|
33
|
Epileptic EEG discharges and short non-convulsive crisis: Influence on cognitive and psychobehavioural functions in youths.
|
Clin Invest Med
|
2008
|
0.75
|
|
34
|
Chest Radiographs Immediately After Cardiac Surgery.
|
Am J Med Qual
|
2016
|
0.75
|